Literature DB >> 8267690

Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors.

M A Lipes1, A Rosenzweig, K N Tan, G Tanigawa, D Ladd, J G Seidman, G S Eisenbarth.   

Abstract

The T cell receptor (TCR) requirements in the pathogenesis of insulin-dependent diabetes were examined with transgenic NOD mice bearing nondisease-related TCR alpha and beta chains. In both TCR beta and TCR alpha beta transgenic NOD mice the beta chain transgene was expressed by > 98% of peripheral T cells. The alpha chain transgene was also highly expressed. Insulitis developed in both sets of transgenic animals with most of the lymphocytes in the lesion expressing the transgenic beta chain and with depletion of the endogenous TCR V beta genes. Nonetheless, NOD animals transgenic for TCR beta and TCR alpha beta developed diabetes similar to controls. Thus, skewing the TCR repertoire did not diminish autoimmune susceptibility in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267690     DOI: 10.1126/science.8267690

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy.

Authors:  H Wakasaki; D Koya; F J Schoen; M R Jirousek; D K Ways; B D Hoit; R A Walsh; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Functionalization of Alginate with Extracellular Matrix Peptides Enhances Viability and Function of Encapsulated Porcine Islets.

Authors:  Juan D Medina; Michael Alexander; Michael D Hunckler; Marc A Fernández-Yagüe; María M Coronel; Alexandra M Smink; Jonathan R Lakey; Paul de Vos; Andrés J García
Journal:  Adv Healthc Mater       Date:  2020-04-07       Impact factor: 9.933

4.  Insulin-secreting non-islet cells are resistant to autoimmune destruction.

Authors:  M A Lipes; E M Cooper; R Skelly; C J Rhodes; E Boschetti; G C Weir; A M Davalli
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Authors:  E Simone; D Daniel; N Schloot; P Gottlieb; S Babu; E Kawasaki; D Wegmann; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes.

Authors:  T Arndt; D Wedekind; H Weiss; M Tiedge; S Lenzen; H-J Hedrich; A Jörns
Journal:  Diabetologia       Date:  2009-04-15       Impact factor: 10.122

7.  Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.

Authors:  Joanna Kern; Robert Drutel; Silvia Leanhart; Marek Bogacz; Rafal Pacholczyk
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

8.  Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice.

Authors:  W R Heath; J F Miller
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

9.  CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.

Authors:  Kristin V Tarbell; Mark Lee; Erik Ranheim; Cheng Chi Chao; Maija Sanna; Seon-Kyeong Kim; Peter Dickie; Luc Teyton; Mark Davis; Hugh McDevitt
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

10.  CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.

Authors:  I Akhtar; J P Gold; L Y Pan; J L Ferrara; X D Yang; J I Kim; K N Tan
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.